Pretargeted α Emitting Radioimmunotherapy Using 213Bi 1,4,7,10-Tetraazacyclododecane-N,N′,N″,N‴-Tetraacetic Acid-Biotin Academic Article Article uri icon

Overview

MeSH Major

  • Neoplasms
  • Radioimmunotherapy

abstract

  • (213)Bi-DOTA-biotin, directed by the Pretarget method to tumor-targeted B3-SA, showed a therapeutic effect, although the therapeutic index was low. The source of the toxicity was most likely related to the renal toxicity.

publication date

  • May 2004

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-03-0171

PubMed ID

  • 15131055

Additional Document Info

start page

  • 3137

end page

  • 46

volume

  • 10

number

  • 9